Oleg M. Korzinov

Alpha-Beta Technology, Inc. engages in the discovery, development and commercialization of novel carbohydrate-based products for the prevention and treatment of infectious disease. It develops a novel class of immune modulation pharmaceutical products composed of complex carbohydrates and is discovering and developing new anti-fungal diagnostics and drugs. In addition, Alpha-Beta has developed a rapid in vitro diagnostic to detect and monitor systemic fungal infections and has an anti-fungal research program to discover direct inhibitors of fungal cell wall synthesis. It is in the development stage and is devoting substantially all of its efforts toward product research and development, raising capital, marketing products under development, clinical trials and manufacturing. The Company was founded on March 2, 1988 and is headquartered in Worcester, MA.

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA.

FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA.

Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA.

ChemDiv, Inc. operates as a discovery and development contract research organization. It specializes in early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. The firm?s services include synthetic chemistry, structural biology and structure-based drug discovery, molecular modeling, medicinal chemistry, scale-up, biochemical and cellular assay development, analytical/bioanalytical platforms, ADME/tox, DMPK, and multiple in vivo efficacy/tox models. The company was founded by Alexander Ivachtchenko in 1991 and is headquartered in San Diego, CA.

Avineuro Pharmaceuticals, Inc. discovers and develops novel small molecules for unmet medical needs in neurology and psychiatry. The company was founded by Alexandre V. Ivachtchenko in August 2008 and is headquartered in Hallandale Beach, FL.

Mosaic Biosciences, Inc. provides commercial research and development services. It conducts research on synthetic materials that support native tissue regeneration. The firm's solutions are designed for application in wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers. The company was founded by Martin Stanton, Chris Bowman, Kristi S. Anseth and Peter Mariner in 2009 and is headquartered in Boulder, CO.

Layerbio, Inc. develops bio erodible sustained-release technology for use in standard intraocular lens in cataract surgery. The private company is based in Lexington, MA. The company was founded in 2013 by Kenneth J. Mandell, Paula Hammond. Kenneth J. Mandell has been the CEO since 2013.

HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts.

Part of Sanofi, BioSurface Technology, Inc. is a commercial biotechnical research company. The company is based in Cambridge, MA. The company was founded by David L. Castaldi, Ben R. Bronstein. BioSurface Technology was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on December 16, 1994.

Upstate Group LLC develops cell signaling products, technology platforms and services. It provides researchers at pharmaceutical and biotechnology companies, universities and government agencies with advanced tools to accelerate life science research and drug discovery. Upstate Group is a subsidiary of Serologicals Corp. The company was founded in 1988 and is headquartered in Charlottesville, VA.

Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.

Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California.

Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California.

Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.

ChemRar High-Tech Center provides investment services to biotech start-ups and research and development companies. It develops and commercializes medicines with therapeutic potential for Russia and ultimately the global market. The company was founded by Alexander Vasilievich Ivaschenko in 1990 and is headquartered in Khimki, Russia.

NewVac LLC is a holding company, which engages in the development of cancer therapy methods. The firm focuses in the investigation of the effectiveness and development of therapeutic vaccines and new indications registered as immunotherapeutic methods in oncology. It also specializes in personalized medicine, combination of cancer therapy, and GMP production of vaccines and cellular products. The company was founded in 2010 and is headquartered in Khimki, Russia.

SatRx LLC provides pharmaceutical and pre-clinical development services. The private company is based in Moscow, Russian Federation. The Russian company was founded in 2010 by Yuliya Aleksandrovna Baybikova. The CEO is Oleg Igorevich Astafurov.

Chromis Therapeutics, Inc. focuses on the development of curative treatments for chronic HBV infection, based on its advanced proprietary drug design and discovery platform. Its CHR101 has a potential to eradicate HBV and to efficiently cure chronically infected HBV patients, as compared to drugs currently on the market. The company was founded by Vadim Bichko and is headquartered in San Diego, CA.

Part of HealthCare Ventures LLC, Healthcare Strategic Partners, LLC is an American company that provides healthcare services.

Alla Chem LLC is a pharmaceutical company that develops pharmaceutical products. The private company is based in Hallandale Beach, FL and was founded in 2004.

Teal Ventures Management LLC (Teal Ventures) is a venture capital firm founded by Nikolay Savchuk, Ron Demuth, and Eddie Rodriguez in 2018. The firm Headquartered in San Diego, California.

Viriom, Inc. is a biotechnology company based in San Diego, CA. The company focuses on developing innovative therapies for infectious diseases, including HIV and COVID-19. Viriom's mission is to improve the lives of patients by providing effective and accessible treatments. Iain David Dukes has been the CEO of the company since 2019, leading the team in their efforts to advance the development of their pipeline and bring new therapies to market.

Lomond Therapeutics, Inc. provides healthcare services. The CEO of the American company is Nikolay Savchuk.

Eil Therapeutics, Inc. offers therapeutic services. The CEO of the American company is Nikolay Savchuk.

Ness Therapeutics, Inc. provides oncology therapeutics. The CEO of the American company is Nikolay Savchuk.

Bala Therapeutics, Inc. is an oncology healthcare company. The company is based in San Diego, CA. The CEO of the company is Nikolay Savchuk.

Celyn Therapeutics, Inc. develops molecule products for clinical use with a focus on targeting cancer.

Trawsfynydd Therapeutics, Inc. engages in discovering and developing antiviral medicines. The company is located in the US.